All Stories

  1. DTH : A nonparametric test for homogeneity of multivariate dispersions
  2. Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data
  3. Impact of Experimental Bias on Compositional Analysis of Microbiome Data
  4. Integrative analysis of microbial 16S gene and shotgun metagenomic sequencing data improves statistical efficiency
  5. What Can We Learn about the Bias of Microbiome Studies from Analyzing Data from Mock Communities?
  6. Testing microbiome associations with survival times at both the community and individual taxon levels
  7. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  8. Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff
  9. Efficient estimation of indirect effects in case‐control studies using a unified likelihood framework
  10. Association Between Fresh Versus Frozen Embryo Transfer on Live Birth Rate Using Data from 8,649 Women in the National Assisted Reproductive Technology Surveillance System
  11. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  12. A rarefaction-based extension of the LDM for testing presence–absence associations in the microbiome
  13. Multisample adjusted U-statistics that account for confounding covariates
  14. PhredEM: a phred-score-informed genotype-calling approach for next-generation sequencing studies
  15. Restoring the Duality between Principal Components of a Distance Matrix and Linear Combinations of Predictors, with Application to Studies of the Microbiome
  16. Testing Rare-Variant Association without Calling Genotypes Allows for Systematic Differences in Sequencing between Cases and Controls
  17. PhredEM: A Phred-Score-Informed Genotype-Calling Approach for Next-Generation Sequencing Studies
  18. Utilizing Population Controls in Rare-Variant Case-Parent Association Tests
  19. Robust Regression Analysis of Copy Number Variation Data based on a Univariate Score
  20. Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case–control study
  21. Risk Assessment and Evaluation of Predictions
  22. A Permutation Procedure to Correct for Confounders in Case-Control Studies, Including Tests of Rare Variation
  23. Stratification-Score Matching Improves Correction for Confounding by Population Stratification in Case-Control Association Studies
  24. Age-associated DNA methylation in pediatric populations
  25. California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study
  26. Maternal smokeless tobacco use in Alaska Native women and singleton infant birth size
  27. Control for Confounding in Case-Control Studies Using the Stratification Score, a Retrospective Balancing Score
  28. A weighted accumulation test for associating rare genetic variation with quantitative phenotypes
  29. Inverse Probability of Censoring Weighted U-statistics for Right-Censored Data with an Application to Testing Hypotheses
  30. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  31. Microdeletions of 3q29 Confer High Risk for Schizophrenia
  32. Late Preterm Birth and Risk of Developing Asthma
  33. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  34. Score-based adjustment for confounding by population stratification in genetic association studies
  35. Fast and Robust Association Tests for Untyped SNPs in Case-Control Studies
  36. SNPs in CAST are associated with Parkinson disease: A confirmation study
  37. A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease
  38. A Regression-based Association Test for Case-control Studies that Uses Inferred Ancestral Haplotype Similarity
  39. Effect of population stratification on the identification of significant single-nucleotide polymorphisms in genome-wide association studies
  40. Genome-wide association analysis of rheumatoid arthritis data via haplotype sharing
  41. MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasiveStreptococcus pyogenesisolates
  42. A Signed-Rank Test for Clustered Data
  43. Response to Lee et al.
  44. Robust estimation and testing of haplotype effects in case-control studies
  45. A Simple and Improved Correction for Population Stratification in Case-Control Studies
  46. Statistical Models for Haplotype Sharing in Case-Parent Trio Data
  47. Inference on haplotype/disease association using parent-affected-child data: the projection conditional on parental haplotypes method
  48. Association mapping via a class of haplotype-sharing statistics
  49. Simple methods for assessing haplotype-environment interactions in case-only and case-control studies
  50. Genetic Studies of a Cluster of Acute Lymphoblastic Leukemia Cases in Churchill County, Nevada
  51. Investigating Childhood Leukemia in Churchill County, Nevada
  52. Comment
  53. Improved association analyses of disease subtypes in case-parent triads
  54. Rank-Sum Tests for Clustered Data
  55. Cross-Sectional Study
  56. Genetic Association Analysis Using Data from Triads and Unrelated Subjects
  57. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans
  58. Robust testing of haplotype/disease association
  59. Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens
  60. An empirical bayes adjustment to increase the sensitivity of detecting differentially expressed genes in microarray experiments
  61. Comparison of prospective and retrospective methods for haplotype inference in case-control studies
  62. How special is a 'special' interval: modeling departure from length-biased sampling in renewal processes
  63. Inference on Haplotype Effects in Case-Control Studies Using Unphased Genotype Data
  64. Random error and undercounting in birth defects surveillance data: Implications for inference
  65. Performance Characteristics of a New Less Sensitive HIV-1 Enzyme Immunoassay for Use in Estimating HIV Seroincidence
  66. HFE genotype and transferrin saturation in the United States
  67. Estimation of Stage Occupation Probabilities in Multistage Models
  68. Marginal Analyses of Clustered Data When Cluster Size Is Informative
  69. Informative Missingness in Genetic Association Studies: Case-Parent Designs
  70. Bootstrap calibration of TRANSMIT for informative missingness of parental genotype data
  71. Marginal Analyses of Multistage Data
  72. Estimation of Integrated Transition Hazards and Stage Occupation Probabilities for Non-Markov Systems Under Dependent Censoring
  73. HIV Seroincidence Among Patients at Clinics for Sexually Transmitted Diseases in Nine Cities in the United States
  74. HIV seroconverting donors delay their return: screening test implications
  75. Subtype-specific Transmission Probabilities for Human Immunodeficiency Virus Type 1 among Injecting Drug Users in Bangkok, Thailand
  76. Midrank unification of rank tests for exact, tied, and censored data
  77. Analysis of Dynamic Cohort Data
  78. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers
  79. Evaluation of a Sensitive/Less-Sensitive Testing Algorithm Using the 3A11-LS Assay for Detecting Recent HIV Seroconversion among Individuals with HIV-1 Subtype B or E Infection in Thailand
  80. Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation
  81. Accounting for Unmeasured Population Substructure in Case-Control Studies of Genetic Association Using a Novel Latent-Class Model
  82. Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses
  83. Nonparametric Estimation for the Three-Stage Irreversible Illness-Death Model
  84. The S-U algorithm for missing data problems
  85. Conditional and Unconditional Categorical Regression Models with Missing Covariates
  86. Repeat Screening for HIV: When to Test and Why
  87. Estimating the Extent of Tracking in Interval-Censored Chain-Of-Events Data
  88. Validating Marker-Based Incidence Estimates in Repeatedly Screened Populations
  89. Detection of Early HIV Infection and Estimation of Incidence Using a Sensitive/Less-Sensitive Enzyme Immunoassay Testing Strategy at Anonymous Counseling and Testing Sites in San Francisco
  90. Hold everything! Holding policies for protecting plasma supplies
  91. Fitting Semi-Markov Models to Interval-Censored Data with Unknown Initiation Times
  92. Discrete-Time Nonparametric Estimation for Semi-Markov Models of Chain-of-Events Data Subject to Interval Censoring and Truncation
  93. Kaplan–Meier representation of competing risk estimates
  94. HIV Seroincidence and Risk Factors Among Patients Repeatedly Tested for HIV Attending Sexually Transmitted Disease Clinics in the United States, 1991 to 1996
  95. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis
  96. New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
  97. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  98. Inference Based on Imputed Failure Times for the Proportional Hazards Model with Interval-Censored Data
  99. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
  100. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire
  101. Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors
  102. Markov Chains With Measurement Error: Estimating the `True' Course of a Marker of the Progression of Human Immunodeficiency Virus Disease
  103. Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States
  104. Upper and Lower Bound Distributions that Give Simultaneous Confidence Intervals for Quantiles
  105. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors
  106. Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia
  107. Estimation of Incidence of HIV Infection Using Cross-Sectional Marker Surveys
  108. Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus
  109. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group
  110. Probability of female-to-male transmission of HIV-1 in Thailand
  111. Conditional Regression Analysis of the Exposure-Disease Odds Ratio Using Known Probability-of-Exposure Values
  112. [Backcalculation of HIV Infection Rates]: Comment
  113. Inferences About Exposure-Disease Associations Using Probability-of-Exposure Information
  114. Inferences About Exposure-Disease Associations Using Probability-of- Exposure Information
  115. HIV Infection among Patients in U.S. Acute Care Hospitals
  116. Continued Fraction Representation for Expected Cell Counts of a 2 x 2 Table: A Rapid and Exact Method for Conditional Maximum Likelihood Estimation
  117. Sample size determination for pair-matched case-control studies where the goal is interval estimation of the odds ratio
  118. Critical phenomena in randomly stirred fluids: Correlation functions, equation of motion, and crossover behavior
  119. Critical phenomena in randomly stirred fluids
  120. Modification of nonequilibrium fluctuations by interaction with surfaces